Literature DB >> 16157731

Prevention strategies for asthma--secondary prevention.

.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16157731      PMCID： PMC1329949     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  27 in total

Review 1.  Childhood risk factors for atopy and the importance of early intervention.

Authors:  U Wahn; E von Mutius
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

2.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

3.  Natural course of sensitization to food and inhalant allergens during the first 6 years of life.

Authors:  M Kulig; R Bergmann; U Klettke; V Wahn; U Tacke; U Wahn
Journal:  J Allergy Clin Immunol       Date:  1999-06       Impact factor: 10.793

4.  Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study.

Authors:  G B Pajno; G Barberio; F De Luca; L Morabito; S Parmiani
Journal:  Clin Exp Allergy       Date:  2001-09       Impact factor: 5.018

5.  Prevention of acute urticaria in young children with atopic dermatitis.

Authors:  F E Simons
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

Review 6.  Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma?

Authors:  F E Simons
Journal:  Clin Exp Allergy       Date:  1999-07       Impact factor: 5.018

Review 7.  Cytokine-directed therapies for asthma.

Authors:  P J Barnes
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

8.  Advising parents of asthmatic children on passive smoking: randomised controlled trial.

Authors:  L Irvine; I K Crombie; R A Clark; P W Slane; C Feyerabend; K E Goodman; J I Cater
Journal:  BMJ       Date:  1999-05-29

9.  Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness.

Authors:  R D Grembiale; L Camporota; S Naty; C M Tranfa; R Djukanovic; S A Marsico
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

10.  Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Authors:  B Knorr; L M Franchi; H Bisgaard; J H Vermeulen; P LeSouef; N Santanello; T M Michele; T F Reiss; H H Nguyen; D L Bratton
Journal:  Pediatrics       Date:  2001-09       Impact factor: 7.124
View more
  2 in total

Review 1.  A new model for environmental assessment and exposure reduction.

Authors:  Christina E Ciaccio; Kevin Kennedy; Jay M Portnoy
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

2.  Environmental assessment and exposure control: a practice parameter--furry animals.

Authors:  Jay Portnoy; Kevin Kennedy; James Sublett; Wanda Phipatanakul; Elizabeth Matsui; Charles Barnes; Carl Grimes; J David Miller; James M Seltzer; P Brock Williams; Jonathan A Bernstein; David I Bernstein; Joann Blessing-Moore; Linda Cox; David A Khan; David M Lang; Richard A Nicklas; John Oppenheimer
Journal:  Ann Allergy Asthma Immunol       Date:  2012-04       Impact factor: 6.347
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.